1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

GSK Vaccines Clinical Bioanalytical Laboratory

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Location

Germany

Primary Industry

Pharmaceuticals

About

Established in Germany, GSK Vaccines Clinical Bioanalytical Laboratory operates as a provider and developer of vaccines, medicines, and drugs for its pharmaceutical clients and biopharmaceutical industries.
Current Investors
Pacific Biomarkers / NEOMED-LABS

Request a demo to show more

Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Verticals
Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only

Deals

Deals Type
Add-on
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Completed GSK Vaccines Clinical Bioanalytical Laboratory 20 Jan 2021
Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.